About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ptentm2.1Gle
targeted mutation 2.1, Gustavo Leone
MGI:4442331
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ptentm2.1Gle/Ptentm2.1Gle involves: 129S6/SvEvTac * Black Swiss * FVB/N MGI:4442334
ht2
Ptentm2.1Gle/Pten+ involves: 129S6/SvEvTac * Black Swiss * FVB/N MGI:4442335


Genotype
MGI:4442334
hm1
Allelic
Composition
Ptentm2.1Gle/Ptentm2.1Gle
Genetic
Background
involves: 129S6/SvEvTac * Black Swiss * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm2.1Gle mutation (0 available); any Pten mutation (88 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging

embryo
• failure of axial rotation
• defects in anterior-posterior patterning
• absence of overt tissue differentiation




Genotype
MGI:4442335
ht2
Allelic
Composition
Ptentm2.1Gle/Pten+
Genetic
Background
involves: 129S6/SvEvTac * Black Swiss * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptentm2.1Gle mutation (0 available); any Pten mutation (88 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 70.7% of 9 month old mice develop proliferative lesions of the adrenal gland
• 81.6% of 9 month old mice develop proliferative lesions of the thyroid
• mammary intraepithelial neoplasia in females
• females develop large palpable tumors with adenosquamous morphology and a prominent stromal component
• increased coincidence in females of mammary tumor and lymph node neoplasms
• a few males develop high grade mammary intraepithelial neoplasia
• adenosquamous carcinoma
• 86.4% of 9 month old mice develop proliferative lesions of the prostate
• 55.8% of 9 month old mice develop proliferative lesions of the lymph node
• increased coincidence of lymph node neoplasms and mammary tumors in females
• 59.5% of 9 month old mice develop proliferative lesions of the thymus

endocrine/exocrine glands
• 70.7% of 9 month old mice develop proliferative lesions of the adrenal gland
• 59.5% of 9 month old mice develop proliferative lesions of the thymus
• thyroid follicular lesions
• 81.6% of 9 month old mice develop proliferative lesions of the thyroid
• increased coincidence in females of mammary tumor and lymph node neoplasms
• mammary intraepithelial neoplasia in females
• females develop large palpable tumors with adenosquamous morphology and a prominent stromal component
• a few males develop high grade mammary intraepithelial neoplasia
• adenosquamous carcinoma
• 86.4% of 9 month old mice develop proliferative lesions of the prostate

reproductive system
• 86.4% of 9 month old mice develop proliferative lesions of the prostate
• proliferative lesions of the endometrium, simple hyperplasia and atypical hyperplasia

integument
• mammary intraepithelial neoplasia in females
• females develop large palpable tumors with adenosquamous morphology and a prominent stromal component
• increased coincidence in females of mammary tumor and lymph node neoplasms
• a few males develop high grade mammary intraepithelial neoplasia
• adenosquamous carcinoma

immune system
• 59.5% of 9 month old mice develop proliferative lesions of the thymus

hematopoietic system
• 59.5% of 9 month old mice develop proliferative lesions of the thymus

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Cowden syndrome DOID:6457 OMIM:PS158350
J:158751





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory